Trecovirsen

Drug Profile

Trecovirsen

Alternative Names: GEM 91; Gene Expression Modulator 91; HYB 0047

Latest Information Update: 12 Feb 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Idera Pharmaceuticals
  • Class Antisense oligonucleotides; Antivirals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections; HIV-1 infections

Most Recent Events

  • 12 Feb 1999 GEM 91 is now called trecovirsen
  • 04 Aug 1997 Discontinued-II for HIV infections treatment in Puerto Rico (IV-infusion)
  • 04 Aug 1997 Discontinued-II for HIV infections treatment in United Kingdom (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top